Draw
Home Products

AG00H0X2

90357-06-5 | Bicalutamide

90357-06-5
AG00H0X2
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 90357-06-5
Catalog Number AG00H0X2(AGN-PC-00TUFT)
Chemical Name Bicalutamide
EC Number 618-534-3
IUPAC Name N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide
InChI InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)
InChI Key LKJPYSCBVHEWIU-UHFFFAOYSA-N
MDL Number MFCD00869971
Molecular Formula C18H14F4N2O4S
Molecular Weight 430.3734
SMILES C(F)(F)(F)c1c(C#N)ccc(c1)NC(=O)C(CS(=O)(=O)c1ccc(cc1)F)(C)O
Synonyms
4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide, bicalutamide, Casodex, Cosudex, ICI 176334, ICI-176334, bicalutamide, 90357-06-5, Casodex, Cosudex, Calutide, ICI 176334, ICI-176334, Bicalutamide (CDX), Kalumid, Bicalutamide(Casodex), N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide, Bicalutamide (Casodex), CHEMBL409, BRN 5364666, LKJPYSCBVHEWIU-UHFFFAOYSA-N, MFCD00869971, (+-)-4'-Cyano-alpha,alpha,alpha-trifluoro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide, C18H14F4N2O4S, ICI 176,334, CPD000466329, bicalutamida, bicalutamidum, N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide, Propanamide, N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methyl-, (+-)-, Raffolutil, N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methylpropanamide, Propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-, SMR000466329, Casodex (TN), Bicalutamide [USAN:INN:BAN], SR-01000759410, Bicalutamine, Bicalutamide (JAN/USP/INN), CCRIS 8728, HSDB 7655, Bicalutamide [USAN:USP:INN:BAN], Bicalutamide, 97%, KS-1161, Bicalutamide - Casodex, PubChem18237, AC1L1DJE, SCHEMBL3611, MLS000759437, MLS001424047, GTPL2863, PRO113, DTXSID2022678, BDBM18525, CHEBI:91617, KS-00000XEI, AOB5596, EX-A962, BCPP000337, HMS2051B13, HMS2089N12, HMS2232H03, HMS3263M13, HMS3372K05, HMS3393B13, HMS3654K18, HMS3714P13, Pharmakon1600-01504827, ACT06291, BCP02110, Tox21_501026, AN-582, CB0180, NSC722665, NSC759816, s1190, AKOS015895073, AC-4232, API0001710, AT-9158, BCP9000408, CCG-100951, CCG-220876, CCG-222330, CS-1296, DB01128, LP01026, NC00201, NSC-722665, NSC-759816, SB17301, N-(4-cyano-3-(trifluoromethyl)phenyl), NCGC00167977-01, NCGC00167977-02, NCGC00167977-03, NCGC00167977-09, NCGC00261711-01, AK544272, BC204097, HY-14249, SAM001246612, SC-17332, AB0008136, LS-119125, TL8005814, B3206, FT-0080576, FT-0618286, SW197581-4, Bicalutamide (CDX), >=98% (HPLC), powder, C08160, D00961, J10442, AB00639963-06, AB00639963-08, AB00639963-09, AB00639963_10, 357B065, A803039, I06-0475, I06-0480, SR-01000759410-4, SR-01000759410-5, BRD-A29485665-001-03-7, Bicalutamide, British Pharmacopoeia (BP) Reference Standard, Bicalutamide, European Pharmacopoeia (EP) Reference Standard, Bicalutamide, United States Pharmacopeia (USP) Reference Standard, 4'-cyano-3-[(4- fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-3'-trifluoromethylpropionanilide, 4'-cyano-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-3'-trifluoromethylpropionanilide, Bicalutamide for system suitability, European Pharmacopoeia (EP) Reference Standard, Bicalutamide, Pharmaceutical Secondary Standard; Certified Reference Material, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methyl-propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-methyl-2-oxidanyl-propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorobenzene)sulfonyl]-2-hydroxy-2-methylpropanamide, N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropionamide, N-[4-cyano-3-trifluoromethyl-phenyl]-3-[4-fluorophenyl-sulfonyl]-2-hydroxy-2-methyl-propionamide, propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-,(+-), Propanamide, Propanamide,, (R)-Bicalutamide, (S)-Bicalutamide, Calutide (TN), Cosudex (TN), Kalumid (TN), UNII-A0Z3NAU9DP, A0Z3NAU9DP, D0V9BD, Astra brand of bicalutamide, Zeneca brand of bicalutamide, -3-(4-fluorophenylsulfonyl), -2-hydroxy-2-methylpropanamide, Bicalutamide [USAN:BAN:INN], AstraZeneca brand of bicalutamide, Bicalutamide, 99% - 1G 1g, CID2375, CS-O-01015, C18-H14-F4-N2-O4-S, A5065, C053541, Casodex, Cosudex, Calutide, Kalumid, Bicalutamide, 113299-40-4, 4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide, 4-cyano-3-trifluoromethyl-N-(3-p-fluorophenylsulfonyl-2-hydroxy-2-methylpropionyl)aniline, (2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide, (2R)-N-[4-CYANO-3-(TRIFLUOROMETHYL)PHENYL]-3-[(4-FLUOROPHENYL)SULFONYL]-2-HYDROXY-2-METHYLPROPANAMIDE, 113299-38-0, N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methyl-propanamide, Propanamida, N-[4-ciano-3-(trifluorometil)] fenil-3-[(4-fluorofenil) sulfonil]-2-hidroxi-2-metil-,

Product Recommendations

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited